Episode Details

UnitedHealth Group's Q2 2026 results prove that intentionally shrinking your customer base can be highly profitable when ruthlessly protecting margins.

In ~10 minutes:

• Shedding 1.1M Medicare members to defend a 3% margin floor.

• How the No Surprises Act is bleeding commercial health insurance.

• Flipping internal prior-authorization AI into external SaaS revenue.

• Doubling full-year stock repurchases to at least $5 billion.

Despite stagnant revenue growth, UNH massively grew bottom-line EPS to $6.38 by aggressively optimizing its Medical Care Ratio (MCR) down to 86.7%. Even with a raised full-year guidance and an industry-shifting move toward 100% pass-through drug rebates, the market faded the stock's pre-market pop as Wall Street digests delayed commercial recoveries and regulatory headaches. 📉

UnitedHealth Group (UNH) | Q2 FY2026

AI-assisted production. Feedback/ticker requests: https://x.com/EarnUnscripted.